The level of IL-6 was elevated in the TME of a prostate cancer model due to TAM activation and tumor cell secretion induced by β-AR signaling (Powell et al., 2013; Cheng et al., 2019). The gene discussed is ADRB2; the disease is prostate carcinoma.